Brexpiprazole
Brexpiprazole is a small molecule acting as a partial agonist at human serotonin 5-HT1A and dopamine D2 receptors. It is widely used in preclinical research to investigate neuropsychiatric disorders, including schizophrenia and depression, through both in vitro binding assays and in vivo behavioral models.
Product Specifications
CAS Number
913611-97-9
Product Name Alternative
Serotonin Receptor, recognition deficits, α1B-adrenergic receptor, α2C receptors, antipsychotic, 5-hydroxytryptamine Receptor, 5HTReceptor, 5-HT2A, 5-HT1A, 5HT Receptor, 5-HT Receptor, AdrenergicReceptor, Adrenergic Receptor, Brexpiprazole, Beta Receptor, DopamineReceptor, Dopamine Receptor, Dopamine, D2L, PC12, OPC34712, OPC-34712, OPC 34712, orally active, neurite outgrowth, inhibit, Inhibitor
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
99.06% (May vary between batches)
Solubility
DMSO:21 mg/mL (48.44 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble)
Smiles
C (CCCOC=1C=C2C (=CC1) C=CC (=O) N2) N3CCN (C4=C5C (SC=C5) =CC=C4) CC3
Molecular Formula
C25H27N3O2S
Molecular Weight
433.57
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
